Congress moves to ban abortion pills by mail, overriding FDA approval
H.R. 9421 — Ban Abortion by Mail Act · Filed by Sheri Biggs (R-SC) · 11 cosponsors · Introduced Jun 24, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill prohibits doctors certified to prescribe mifepristone (the abortion pill) from doing so without an in-person visit with the patient and a medical license in the patient's state. Providers who violate either requirement lose their certification to prescribe the drug for at least 2 years. The bill effectively bans mail-order abortion medication by making remote prescribing illegal.
Why we flagged it
The bill's operative mechanism is a direct restriction on how a specific medication can be prescribed, targeting the telehealth delivery model. Despite framing around REMS safety protocols, the bill's functional effect is to eliminate mail-order abortion access.
What the text implies
- The in-person visit requirement may effectively require patients to travel to states where abortion is legal if their home state has banned the procedure, creating a de facto interstate travel barrier.
- The state-licensing requirement could prevent providers in states with legal abortion from serving patients in neighboring states, fragmenting the telehealth market and reducing access in rural areas.
- The 2-year decertification penalty is severe enough to deter compliance with the rule, potentially driving compliant providers out of mifepristone prescribing entirely.
- The bill's definition of 'abortion drug' is expansive ('any drug...intended for use...to intentionally kill the unborn child') and could capture drugs used for other purposes if intent is disputed.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill restricts access to a medication approved by the FDA and currently available through telehealth in many states. Patients in states where providers lack licenses or who cannot travel for in-person visits lose access to a legal medical option, reducing reproductive autonomy and forcing some to travel interstate or forgo the procedure entirely.
Named in the bill
FDA, HHS, REMS Program, mifepristone, House Committee on Energy and Commerce
Where it stands
11 cosponsors: 11 Republicans.
- Jun 24, 2026 — Introduced · Congress.gov: “Introduced in House”
- Jun 24, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $420,000 in lobbying spend. A filing names 51 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Sheri Biggs, the sponsor, reported $320,825 in PAC receipts in the 2026 cycle.
- Susan B Anthony List — $420,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (2,756 characters) on Aug 15, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress moves to ban abortion pills by mail, overriding FDA approval” QuorumCivic. https://share.quorumcivic.app/bill/119/hr9421 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.